
Glimimore MF 2mg/1000mg Tablet SR
Marketer
Morepen Laboratories Ltd
Salt Composition
Glimepiride (2mg) + Metformin (1000mg)
Overview Glimimore MF 2mg/1000mg Tablet SR
Diabex Duo 2mg/1000mg Extended-Release Tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate blood glucose, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms; maintain regular meals and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any pre-existing heart conditions before commencing treatment, as it may not be appropriate. Pregnant or breastfeeding individuals should consult their physician before use. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.
Uses of Glimimore MF 2mg/1000mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimimore MF 2mg/1000mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimimore MF 2mg/1000mg Extended-Release tablets with food.
Common Side effects of Glimimore MF 2mg/1000mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimimore MF 2mg/1000mg Tablet SR:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimimore MF 2mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this extended-release tablet with a meal.
How Glimimore MF 2mg/1000mg Tablet SR works:
Glimimore MF 2mg/1000mg Extended-Release tablets combine glimepiride and metformin, two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimimore MF 2mg/1000mg Tablet SR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimimore MF 2mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingUNSAFE
Extended-release Glimimore MF tablets (2mg/1000mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimimore MF 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimimore MF 2mg/1000mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Initiation with a low dose is typical for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimimore MF 2mg/1000mg Tablet SR :
Should you forget a dose of Glimimore MF 2mg/1000mg sustained-release tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimimore MF 2mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
